nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00136	CcSEcCtD
Glycopyrrolate—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00136	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00135	CcSEcCtD
Glycopyrrolate—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00134	CcSEcCtD
Glycopyrrolate—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00134	CcSEcCtD
Glycopyrrolate—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00133	CcSEcCtD
Glycopyrrolate—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00133	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Glycopyrrolate—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Glycopyrrolate—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Glycopyrrolate—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00132	CcSEcCtD
Glycopyrrolate—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0012	0.0013	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.0013	CcSEcCtD
Glycopyrrolate—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.0013	CcSEcCtD
Glycopyrrolate—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.0013	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.0013	CcSEcCtD
Glycopyrrolate—Tension—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00129	CcSEcCtD
Glycopyrrolate—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00129	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Glycopyrrolate—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Glycopyrrolate—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00128	CcSEcCtD
Glycopyrrolate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00127	CcSEcCtD
Glycopyrrolate—Rash—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Glycopyrrolate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Glycopyrrolate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00126	CcSEcCtD
Glycopyrrolate—Headache—Didanosine—acquired immunodeficiency syndrome	0.00116	0.00125	CcSEcCtD
Glycopyrrolate—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00115	0.00125	CcSEcCtD
Glycopyrrolate—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00125	CcSEcCtD
Glycopyrrolate—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00115	0.00124	CcSEcCtD
Glycopyrrolate—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00124	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.00124	CcSEcCtD
Glycopyrrolate—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00124	CcSEcCtD
Glycopyrrolate—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00124	CcSEcCtD
Glycopyrrolate—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00123	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00123	CcSEcCtD
Glycopyrrolate—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00123	CcSEcCtD
Glycopyrrolate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00123	CcSEcCtD
Glycopyrrolate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00123	CcSEcCtD
Glycopyrrolate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00113	0.00122	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00122	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Glycopyrrolate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Glycopyrrolate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00121	CcSEcCtD
Glycopyrrolate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Glycopyrrolate—Pain—Indinavir—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Glycopyrrolate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Glycopyrrolate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Glycopyrrolate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.0012	CcSEcCtD
Glycopyrrolate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Glycopyrrolate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Glycopyrrolate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Glycopyrrolate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Glycopyrrolate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0011	0.00119	CcSEcCtD
Glycopyrrolate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00118	CcSEcCtD
Glycopyrrolate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00118	CcSEcCtD
Glycopyrrolate—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00118	CcSEcCtD
Glycopyrrolate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00117	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00117	CcSEcCtD
Glycopyrrolate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00116	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00115	CcSEcCtD
Glycopyrrolate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00115	CcSEcCtD
Glycopyrrolate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00114	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00114	CcSEcCtD
Glycopyrrolate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00114	CcSEcCtD
Glycopyrrolate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00114	CcSEcCtD
Glycopyrrolate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00114	CcSEcCtD
Glycopyrrolate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00114	CcSEcCtD
Glycopyrrolate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00114	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Glycopyrrolate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Glycopyrrolate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Glycopyrrolate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Glycopyrrolate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Glycopyrrolate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Glycopyrrolate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Glycopyrrolate—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Glycopyrrolate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Glycopyrrolate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Glycopyrrolate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Glycopyrrolate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Glycopyrrolate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Glycopyrrolate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Glycopyrrolate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Glycopyrrolate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00102	0.0011	CcSEcCtD
Glycopyrrolate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0011	CcSEcCtD
Glycopyrrolate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.0011	CcSEcCtD
Glycopyrrolate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Rash—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Glycopyrrolate—Headache—Stavudine—acquired immunodeficiency syndrome	0.001	0.00109	CcSEcCtD
Glycopyrrolate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.001	0.00109	CcSEcCtD
Glycopyrrolate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Glycopyrrolate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Glycopyrrolate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Glycopyrrolate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000999	0.00108	CcSEcCtD
Glycopyrrolate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000995	0.00108	CcSEcCtD
Glycopyrrolate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000994	0.00108	CcSEcCtD
Glycopyrrolate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000994	0.00108	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000994	0.00108	CcSEcCtD
Glycopyrrolate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000989	0.00107	CcSEcCtD
Glycopyrrolate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000988	0.00107	CcSEcCtD
Glycopyrrolate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000986	0.00107	CcSEcCtD
Glycopyrrolate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000985	0.00107	CcSEcCtD
Glycopyrrolate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000979	0.00106	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000975	0.00105	CcSEcCtD
Glycopyrrolate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000974	0.00105	CcSEcCtD
Glycopyrrolate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000972	0.00105	CcSEcCtD
Glycopyrrolate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000968	0.00105	CcSEcCtD
Glycopyrrolate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000968	0.00105	CcSEcCtD
Glycopyrrolate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000966	0.00104	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000965	0.00104	CcSEcCtD
Glycopyrrolate—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000963	0.00104	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000961	0.00104	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000958	0.00104	CcSEcCtD
Glycopyrrolate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000955	0.00103	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000954	0.00103	CcSEcCtD
Glycopyrrolate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000953	0.00103	CcSEcCtD
Glycopyrrolate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000952	0.00103	CcSEcCtD
Glycopyrrolate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000943	0.00102	CcSEcCtD
Glycopyrrolate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000938	0.00101	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000935	0.00101	CcSEcCtD
Glycopyrrolate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000934	0.00101	CcSEcCtD
Glycopyrrolate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00093	0.00101	CcSEcCtD
Glycopyrrolate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000929	0.001	CcSEcCtD
Glycopyrrolate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000929	0.001	CcSEcCtD
Glycopyrrolate—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000927	0.001	CcSEcCtD
Glycopyrrolate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000926	0.001	CcSEcCtD
Glycopyrrolate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000926	0.001	CcSEcCtD
Glycopyrrolate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.001	CcSEcCtD
Glycopyrrolate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.001	CcSEcCtD
Glycopyrrolate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000921	0.000996	CcSEcCtD
Glycopyrrolate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000917	0.000992	CcSEcCtD
Glycopyrrolate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000916	0.000991	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000902	0.000975	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.0009	0.000973	CcSEcCtD
Glycopyrrolate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000899	0.000972	CcSEcCtD
Glycopyrrolate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000899	0.000972	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000892	0.000965	CcSEcCtD
Glycopyrrolate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000891	0.000964	CcSEcCtD
Glycopyrrolate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000891	0.000964	CcSEcCtD
Glycopyrrolate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000886	0.000958	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000886	0.000957	CcSEcCtD
Glycopyrrolate—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000884	0.000956	CcSEcCtD
Glycopyrrolate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000878	0.00095	CcSEcCtD
Glycopyrrolate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000878	0.000949	CcSEcCtD
Glycopyrrolate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000877	0.000949	CcSEcCtD
Glycopyrrolate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000875	0.000946	CcSEcCtD
Glycopyrrolate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000873	0.000943	CcSEcCtD
Glycopyrrolate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000866	0.000936	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000863	0.000933	CcSEcCtD
Glycopyrrolate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00086	0.00093	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000859	0.000929	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000858	0.000928	CcSEcCtD
Glycopyrrolate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000857	0.000927	CcSEcCtD
Glycopyrrolate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000857	0.000926	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.000926	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.000926	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000852	0.000922	CcSEcCtD
Glycopyrrolate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00085	0.000919	CcSEcCtD
Glycopyrrolate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00085	0.000919	CcSEcCtD
Glycopyrrolate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00084	0.000908	CcSEcCtD
Glycopyrrolate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000828	0.000896	CcSEcCtD
Glycopyrrolate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000828	0.000895	CcSEcCtD
Glycopyrrolate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000827	0.000895	CcSEcCtD
Glycopyrrolate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.000891	CcSEcCtD
Glycopyrrolate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000824	0.000891	CcSEcCtD
Glycopyrrolate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000824	0.000891	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000819	0.000886	CcSEcCtD
Glycopyrrolate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000817	0.000883	CcSEcCtD
Glycopyrrolate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000816	0.000882	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000813	0.000879	CcSEcCtD
Glycopyrrolate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000812	0.000877	CcSEcCtD
Glycopyrrolate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000809	0.000875	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000798	0.000863	CcSEcCtD
Glycopyrrolate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00079	0.000854	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00085	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00085	CcSEcCtD
Glycopyrrolate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000778	0.000841	CcSEcCtD
Glycopyrrolate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000777	0.00084	CcSEcCtD
Glycopyrrolate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000774	0.000837	CcSEcCtD
Glycopyrrolate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000772	0.000834	CcSEcCtD
Glycopyrrolate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000771	0.000834	CcSEcCtD
Glycopyrrolate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000769	0.000832	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000768	0.00083	CcSEcCtD
Glycopyrrolate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000767	0.000829	CcSEcCtD
Glycopyrrolate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000766	0.000828	CcSEcCtD
Glycopyrrolate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000748	0.000809	CcSEcCtD
Glycopyrrolate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000745	0.000805	CcSEcCtD
Glycopyrrolate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000738	0.000798	CcSEcCtD
Glycopyrrolate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000738	0.000798	CcSEcCtD
Glycopyrrolate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000737	0.000797	CcSEcCtD
Glycopyrrolate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000734	0.000793	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000733	0.000792	CcSEcCtD
Glycopyrrolate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000727	0.000786	CcSEcCtD
Glycopyrrolate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000716	0.000774	CcSEcCtD
Glycopyrrolate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000713	0.000771	CcSEcCtD
Glycopyrrolate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000703	0.000761	CcSEcCtD
Glycopyrrolate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000696	0.000752	CcSEcCtD
Glycopyrrolate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000689	0.000745	CcSEcCtD
Glycopyrrolate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000689	0.000744	CcSEcCtD
Glycopyrrolate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000683	0.000738	CcSEcCtD
Glycopyrrolate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000682	0.000738	CcSEcCtD
Glycopyrrolate—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000678	0.000734	CcSEcCtD
Glycopyrrolate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000663	0.000717	CcSEcCtD
Glycopyrrolate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000658	0.000711	CcSEcCtD
Glycopyrrolate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000657	0.000711	CcSEcCtD
Glycopyrrolate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000657	0.00071	CcSEcCtD
Glycopyrrolate—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000653	0.000706	CcSEcCtD
Glycopyrrolate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000643	0.000695	CcSEcCtD
Glycopyrrolate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.000684	CcSEcCtD
Glycopyrrolate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000627	0.000678	CcSEcCtD
Glycopyrrolate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.000677	CcSEcCtD
Glycopyrrolate—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000623	0.000674	CcSEcCtD
Glycopyrrolate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000619	0.000669	CcSEcCtD
Glycopyrrolate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000591	0.000639	CcSEcCtD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000421	0.0058	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000403	0.00555	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000396	0.00545	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000396	0.00545	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000387	0.00533	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000386	0.00531	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000382	0.00526	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000379	0.00522	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000379	0.00522	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000379	0.00522	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000355	0.00488	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000353	0.00485	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00035	0.00482	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000349	0.0048	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000349	0.0048	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000346	0.00476	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000341	0.0047	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00034	0.00468	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000332	0.00456	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000332	0.00456	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000331	0.00456	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00033	0.00455	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000328	0.00451	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000327	0.0045	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000327	0.0045	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000324	0.00446	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000321	0.00442	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000317	0.00436	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000314	0.00432	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000313	0.00431	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000312	0.00429	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000311	0.00428	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00031	0.00427	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000308	0.00424	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000307	0.00423	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000303	0.00418	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000302	0.00415	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000302	0.00415	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000301	0.00415	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000295	0.00406	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000289	0.00398	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000289	0.00398	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000289	0.00397	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000287	0.00395	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000284	0.00391	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000283	0.0039	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000282	0.00388	CbGpPWpGaD
Glycopyrrolate—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000281	0.113	CbGeAlD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00028	0.00386	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000275	0.00379	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000271	0.00374	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000267	0.00368	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000267	0.00368	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000266	0.00367	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000266	0.00366	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000266	0.00366	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000264	0.00363	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000264	0.00363	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00026	0.00358	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000255	0.00351	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000252	0.00347	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000239	0.00329	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000238	0.00328	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000236	0.00325	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000229	0.00316	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000227	0.00313	CbGpPWpGaD
Glycopyrrolate—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000222	0.0893	CbGeAlD
Glycopyrrolate—CHRM5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00022	0.00302	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000216	0.00298	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000216	0.00297	CbGpPWpGaD
Glycopyrrolate—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000214	0.086	CbGeAlD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000214	0.00294	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000213	0.00294	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000213	0.00293	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000211	0.0029	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000207	0.00285	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000206	0.00283	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000203	0.0028	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000203	0.0028	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000203	0.0028	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000203	0.00279	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000203	0.00279	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000202	0.00279	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000201	0.00276	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000201	0.00276	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000201	0.00276	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000199	0.00273	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000198	0.00273	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000198	0.00272	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000196	0.0027	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000194	0.00267	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000193	0.00266	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000191	0.00263	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000183	0.00252	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000182	0.00251	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000182	0.00251	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000181	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000181	0.00249	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00018	0.00247	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000179	0.00247	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000177	0.00244	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000175	0.00241	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000174	0.0024	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000174	0.0024	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000174	0.0024	CbGpPWpGaD
Glycopyrrolate—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000174	0.0698	CbGeAlD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000174	0.00239	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00017	0.00235	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00017	0.00235	CbGpPWpGaD
Glycopyrrolate—CHRM4—brain—acquired immunodeficiency syndrome	0.00017	0.0682	CbGeAlD
Glycopyrrolate—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000167	0.0672	CbGeAlD
Glycopyrrolate—CHRM5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000167	0.00229	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000167	0.00229	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000165	0.00227	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000163	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000163	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000158	0.00217	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000157	0.00217	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000155	0.00213	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000155	0.00213	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000155	0.00213	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000154	0.00212	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000153	0.0021	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000151	0.00207	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000148	0.00204	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000148	0.00204	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000139	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000139	0.00191	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000138	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM5—brain—acquired immunodeficiency syndrome	0.000133	0.0533	CbGeAlD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000133	0.00183	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00013	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000128	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000126	0.0505	CbGeAlD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000124	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000123	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000122	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000122	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000122	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000122	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000121	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000121	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000119	0.0479	CbGeAlD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000119	0.00164	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000118	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000117	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000117	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM1—lung—acquired immunodeficiency syndrome	0.000117	0.0471	CbGeAlD
Glycopyrrolate—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000117	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000117	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000117	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000116	0.0016	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000116	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000116	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000115	0.0461	CbGeAlD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000113	0.00155	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000112	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000111	0.00153	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000111	0.00153	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000111	0.00152	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00011	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000109	0.0436	CbGeAlD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000108	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000107	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000106	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000106	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000106	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000105	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000105	0.042	CbGeAlD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000103	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000103	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000103	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000102	0.0014	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.72e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM3—nervous system—acquired immunodeficiency syndrome	9.72e-05	0.039	CbGeAlD
Glycopyrrolate—CHRM3—central nervous system—acquired immunodeficiency syndrome	9.36e-05	0.0376	CbGeAlD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.31e-05	0.00128	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.14e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.14e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM2—brain—acquired immunodeficiency syndrome	9.12e-05	0.0366	CbGeAlD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	8.86e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.76e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.76e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.74e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.71e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.63e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.61e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.58e-05	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.5e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.39e-05	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.37e-05	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM1—brain—acquired immunodeficiency syndrome	8.3e-05	0.0333	CbGeAlD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.94e-05	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.91e-05	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.88e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.85e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.84e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.82e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.79e-05	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.77e-05	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.72e-05	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM3—brain—acquired immunodeficiency syndrome	7.43e-05	0.0298	CbGeAlD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.25e-05	0.000998	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.23e-05	0.000995	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.16e-05	0.000985	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.15e-05	0.000985	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.13e-05	0.000981	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.06e-05	0.000972	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.96e-05	0.000957	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.85e-05	0.000943	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.75e-05	0.000929	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.66e-05	0.000917	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.56e-05	0.000903	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.56e-05	0.000903	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.54e-05	0.0009	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.47e-05	0.000891	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.46e-05	0.00089	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.27e-05	0.000863	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.16e-05	0.000849	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.16e-05	0.000849	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.14e-05	0.000846	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.14e-05	0.000846	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.13e-05	0.000844	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.09e-05	0.000838	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.09e-05	0.000838	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6e-05	0.000826	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.87e-05	0.000808	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.69e-05	0.000646	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.67e-05	0.000644	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.63e-05	0.000637	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.62e-05	0.000636	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.6e-05	0.000634	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.56e-05	0.000628	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.55e-05	0.000626	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.54e-05	0.000624	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.49e-05	0.000618	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.23e-05	0.000582	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.21e-05	0.00058	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.17e-05	0.000574	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.13e-05	0.000569	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.12e-05	0.000567	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.08e-05	0.000562	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.62e-05	0.000498	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.6e-05	0.000496	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	3.59e-05	0.000494	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.47e-05	0.000477	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-05	0.000475	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.44e-05	0.000336	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.43e-05	0.000335	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000334	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000333	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.41e-05	0.000332	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.4e-05	0.00033	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.13e-05	0.000293	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-05	0.000281	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000195	CbGpPWpGaD
